- A for-profit company that Peter Thiel invests in has plans to start clinical trials of magic mushrooms for depression within the first three months of 2018.
- Psychedelics appear to disrupt the brain's activity patterns in a positive and life-changing way.
- Several research institutions are studying psychedelics for their potential to treat depression, anxiety, addiction, and PTSD.
No comments:
Post a Comment